isocoumarins has been researched along with lactic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Di Stefano, G; Govoni, M; Manerba, M; Vettraino, M | 1 |
Di Ianni, L; Di Stefano, G; Govoni, M; Manerba, M; Recanatini, M; Roberti, M | 1 |
Di Ianni, L; Di Stefano, G; Falchi, F; Giacomini, E; Guidotti, L; Manerba, M; Recanatini, M; Roberti, M; Rupiani, S | 1 |
Schoenrogge, M; Vollmar, B; Wendt, EHU; Zechner, D | 1 |
4 other study(ies) available for isocoumarins and lactic acid
Article | Year |
---|---|
Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.
Topics: Adenosine Triphosphate; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Inhibitory Concentration 50; Isocoumarins; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lactic Acid; NAD; Proto-Oncogene Proteins c-myc; Signal Transduction; Sirtuin 1; Time Factors | 2013 |
Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells.
Topics: Caco-2 Cells; Colonic Neoplasms; Epithelial-Mesenchymal Transition; Humans; Inflammation; Interleukin-17; Isocoumarins; Isoenzymes; L-Lactate Dehydrogenase; Lactic Acid; Oxamic Acid; RNA, Messenger; Tumor Necrosis Factor-alpha | 2017 |
Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A.
Topics: Cell Line; Cell Proliferation; Chemistry Techniques, Synthetic; Enzyme Inhibitors; Humans; Isocoumarins; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lactic Acid | 2016 |
Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells.
Topics: Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Hypoglycemic Agents; Isocoumarins; Lactic Acid; Metformin; Pancreatic Neoplasms | 2020 |